Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | OTLK |
---|---|---|
09:32 ET | 1727 | 8.145 |
09:34 ET | 100 | 8.135 |
09:41 ET | 206 | 8.22 |
09:43 ET | 411 | 8.2582 |
09:45 ET | 1100 | 8.36 |
09:52 ET | 307 | 8.2669 |
09:54 ET | 392 | 8.3 |
09:56 ET | 689 | 8.3 |
10:01 ET | 3425 | 8.395 |
10:03 ET | 116 | 8.44 |
10:06 ET | 500 | 8.4 |
10:08 ET | 600 | 8.3647 |
10:21 ET | 100 | 8.28 |
10:35 ET | 100 | 8.3163 |
10:39 ET | 150 | 8.29 |
10:51 ET | 700 | 8.32 |
10:57 ET | 100 | 8.3 |
11:00 ET | 2691 | 8.4 |
11:02 ET | 400 | 8.48 |
11:04 ET | 514 | 8.38 |
11:06 ET | 3185 | 8.5 |
11:08 ET | 100 | 8.42 |
11:11 ET | 300 | 8.42 |
11:15 ET | 100 | 8.36 |
11:22 ET | 100 | 8.33 |
11:33 ET | 100 | 8.33 |
11:40 ET | 200 | 8.35 |
11:44 ET | 200 | 8.4131 |
11:51 ET | 150 | 8.4001 |
11:54 ET | 300 | 8.42 |
11:56 ET | 700 | 8.41 |
12:00 ET | 200 | 8.42 |
12:03 ET | 400 | 8.4488 |
12:09 ET | 410 | 8.43 |
12:16 ET | 744 | 8.41 |
12:21 ET | 300 | 8.3788 |
12:25 ET | 200 | 8.395 |
12:27 ET | 320 | 8.4 |
12:34 ET | 7809 | 8.3 |
12:36 ET | 100 | 8.303 |
12:39 ET | 100 | 8.33 |
12:41 ET | 2469 | 8.35 |
12:43 ET | 970 | 8.3416 |
12:45 ET | 2697 | 8.35 |
12:48 ET | 2386 | 8.4 |
12:54 ET | 1100 | 8.34 |
12:56 ET | 4100 | 8.3899 |
12:57 ET | 100 | 8.375 |
01:01 ET | 300 | 8.38 |
01:03 ET | 800 | 8.39 |
01:06 ET | 800 | 8.39 |
01:12 ET | 695 | 8.3986 |
01:15 ET | 400 | 8.39 |
01:17 ET | 396 | 8.34 |
01:21 ET | 100 | 8.33 |
01:24 ET | 100 | 8.36 |
01:28 ET | 400 | 8.33 |
01:30 ET | 100 | 8.34 |
01:33 ET | 100 | 8.3 |
01:35 ET | 6438 | 8.38 |
01:37 ET | 8155 | 8.29 |
01:39 ET | 100 | 8.3 |
01:42 ET | 976 | 8.28 |
01:44 ET | 100 | 8.28 |
01:46 ET | 400 | 8.32 |
01:53 ET | 610 | 8.32 |
01:55 ET | 2967 | 8.36 |
02:06 ET | 200 | 8.29 |
02:11 ET | 100 | 8.29 |
02:13 ET | 900 | 8.34 |
02:18 ET | 150 | 8.3273 |
02:20 ET | 2027 | 8.34 |
02:22 ET | 409 | 8.34 |
02:29 ET | 500 | 8.37 |
02:31 ET | 1015 | 8.3985 |
02:36 ET | 414 | 8.36 |
02:44 ET | 1300 | 8.43 |
02:49 ET | 400 | 8.43 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Outlook Therapeutics Inc | 182.6M | -2.1x | --- |
Elevation Oncology Inc | 177.3M | -2.4x | --- |
Omeros Corp | 177.3M | -1.1x | --- |
Candel Therapeutics Inc | 188.7M | -4.9x | --- |
X4 Pharmaceuticals Inc | 189.8M | -2.0x | --- |
Cardiff Oncology Inc | 178.3M | -4.4x | --- |
Outlook Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing ONS-5010 (LYTENAVA (bevacizumab-vikg)), an ophthalmic formulation of bevacizumab for use in retinal indications. The Company's product candidate, ONS-5010, is developed to be administered as an intravitreal injection for the treatment of wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and branch retinal vein occlusion (BRVO). Bevacizumab is a full-length, humanized anti-Vascular Endothelial Growth Factor (VEGF) recombinant monoclonal antibody (mAb), that inhibits VEGF and associated angiogenic activity. VEGF is a protein that promotes the growth of new abnormal blood vessels. Its biologics license application (BLA) for ONS-5010 in wet AMD involved three clinical trials, which include NORSE ONE, NORSE TWO and NORSE THREE. The Company sells ONS-5010 in the United States, United Kingdom, Europe, Japan and other markets.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $182.6M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 22.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.30 |
EPS | $-3.99 |
Book Value | $-1.11 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.